Stock NTP ABLIVA AB
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Abliva AB Deutsche Boerse AG

Equities

NTP

SE0002575340

Delayed Deutsche Boerse AG
Other stock markets
 03:46:25 2024-07-17 EDT 		5-day change 1st Jan Change
0.0128 EUR +0.79% Intraday chart for Abliva AB +70.67% +4.07%
05-30 Abliva Concludes Dosing in Mid-stage Study of Mitochondrial Disease Drug MT
05-30 Abliva AB Announces Completion of 24 Weeks of Dosing in Wave 1 of the Falcon Study of KL1333 in Primary Mitochondrial Disease CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 126B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 118B
ARGENX SE Stock argenx SE
 27.87B -
BIONTECH SE Stock BioNTech SE
 20.95B -
GENMAB A/S Stock Genmab A/S
 16.92B
  1. Stock Market
  2. Equities
  3. ABLI Stock
  4. NTP Stock
  5. Charts Abliva AB
  6. Sector Chart